Sarissa Capital Management’s AbbVie ABBV Stock Holding History

Sarissa Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-310,150	Closed	-$30.4M	–	12
2020 Q2	$30.4M	Buy	310,150 +309,150	+30,915%	+$27.2M	3.39%	9
2020 Q1	$76K	Hold	1,000	–	–	0.01%	11
2019 Q4	$88K	Hold	1,000	–	–	0.01%	13
2019 Q3	$75K	Hold	1,000	–	–	0.01%	12
2019 Q2	$72K	Hold	1,000	–	–	0.01%	13
2019 Q1	$80K	Hold	1,000	–	–	0.01%	10
2018 Q4	$92K	Hold	1,000	–	–	0.02%	9
2018 Q3	$94K	Hold	1,000	–	–	0.02%	9
2018 Q2	$92K	Hold	1,000	–	–	0.02%	10
2018 Q1	$94K	Sell	1,000 -9,000	-90%	-$989K	0.02%	11
2017 Q4	$967K	Hold	10,000	–	–	0.25%	11
2017 Q3	$888K	Hold	10,000	–	–	0.27%	9
2017 Q2	$725K	Hold	10,000	–	–	0.24%	8
2017 Q1	$651K	Hold	10,000	–	–	0.26%	10
2016 Q4	$626K	Sell	10,000 -22,000	-69%	-$1.34M	0.17%	11
2016 Q3	$2.02M	Sell	32,000 -18,000	-36%	-$1.17M	0.46%	13
2016 Q2	$3.1M	Sell	50,000 -1,530,000	-97%	-$93.2M	0.88%	13
2016 Q1	$90.2M	Hold	1,580,000	–	–	19.89%	1
2015 Q4	$93.6M	Hold	1,580,000	–	–	18.2%	2
2015 Q3	$86M	Hold	1,580,000	–	–	21.23%	1
2015 Q2	$106M	Hold	1,580,000	–	–	24.43%	2
2015 Q1	$92.5M	Buy	+1,580,000	New	+$95.5M	19.51%	2
2014 Q1	–	Sell	-250,000	Closed	-$13.2M	–	16
2013 Q4	$13.2M	Buy	+250,000	New	+$12.3M	4.94%	8

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Sarissa Capital Management's ABBV Position: Q3 2020 in Review

Sarissa Capital Management sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 310,150 shares — an estimated $30.4M sold.

Sarissa Capital Management first reported a position in ABBV in Q4 2013 and held it in 23 quarters. The position peaked at $106M in Q2 2015. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

Sarissa Capital Management reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
Sarissa Capital Management sold 310,150 AbbVie shares in Q3 2020, an estimated $30.4M.
Sarissa Capital Management first reported a position in AbbVie in Q4 2013 and held it in 23 quarters.
Sarissa Capital Management's AbbVie position peaked at $106M in Q2 2015.
2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Sarissa Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.